Accent Capital Management’s Eli Lilly LLY Stock Holding History

Accent Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.17M	Sell	5,622 -96	-2%	-$97.3K	2.51%	10
2025 Q4	$6.15M	Sell	5,718 -96	-2%	-$91.8K	2.64%	9
2025 Q3	$4.44M	Buy	5,814 +67	+1%	+$49.9K	1.86%	13
2025 Q2	$4.48M	Sell	5,747 -66	-1%	-$51.3K	2%	12
2025 Q1	$4.8M	Sell	5,813 -73	-1%	-$60.7K	2.77%	10
2024 Q4	$4.54M	Buy	5,886 +3,690	+168%	+$3.06M	2.59%	10
2024 Q3	$1.95M	Sell	2,196 -790	-26%	-$710K	1.12%	16
2024 Q2	$2.7M	Buy	2,986 +12	+0.4%	+$9.6K	1.66%	14
2024 Q1	$2.31M	Buy	2,974 +171	+6%	+$122K	2%	12
2023 Q4	$1.63M	Buy	+2,803	New	+$1.64M	1.29%	17

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Accent Capital Management's LLY Position: Q1 2026 in Review

Accent Capital Management reduced its Eli Lilly (LLY) stake by 1.7% in Q1 2026, selling an estimated $97.3K and leaving 5,622 shares worth $5.17M. The position accounts for 2.51% of the portfolio, ranked #10.

Accent Capital Management first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $6.15M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Accent Capital Management held 5,622 shares of Eli Lilly worth $5.17M as of Q1 2026.
Accent Capital Management sold 96 Eli Lilly shares in Q1 2026, an estimated $97.3K.
Eli Lilly made up 2.51% of Accent Capital Management's portfolio in Q1 2026, its #10 holding.
Accent Capital Management first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
Accent Capital Management's Eli Lilly position peaked at $6.15M in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Accent Capital Management's 13F filing for Q1 2026, filed 11 May 2026.